CA
NZ
UK
AU
IND
US
Levi Strauss & Co officer Jason Gowans filed a Form 144 notice of proposed sale on November 4, 2026, covering 3,494 Class A shares with an aggregate market value of $83,367.68, to be sold on the NYSE through Fidelity Brokerage Services LLC.
David Bernstein, an executive officer of Carnival Corp Ltd., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 26,681 shares of Carnival Corporation common stock on the New York Stock Exchange.
Matthew K. Szot, Chief Financial Officer of Stark Focus Group, Inc., filed an initial statement of beneficial ownership (Form 3) on November 4, 2026, disclosing no securities beneficially owned as of the event date of October 8, 2026.
Director Todd F. Schurz filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 158 shares of 1st Source Corp common stock on November 3, 2026.
The device maker also benefited from a wider move after Democrats won control of Congress, which eased political uncertainty and lifted health stocks. Peers including Medtronic (NYSE:MDT) and Intuitive Surgical (NASDAQ:ISRG) advanced in the same session, and theDow Jones Industrial Averagewas up about 2.9%.
The largest capitated contract drove 10.7 points of organic growth, and itsMarginrose to about 10% from negative 4% in the second quarter, exiting the quarter near 14%. Management targets a 20% margin on that contract by the fourth quarter of next year. RBC reiterated …
In a poorly immunogenic, fast-growing B16F10 melanoma model, daily oral elraglusib significantly slowed tumor growth and was well tolerated. Tumor analysis showed more CD8+ T cells and natural killer cells and fewer myeloid-like suppressor cells, which suggests the treatment shifts the tumor environment toward …
Investors seem to be weighing a flat implied fourth quarter, a decline expected in service revenue, a wider operating loss and the planned retirement of an executive.
The initial after-hours reaction to the results was muted, but analysts moved quickly. UBS raised its target to $530, Goldman Sachs to $536, TD Cowen to $531 and Oppenheimer to $520.
Third-quarter results are due, with sources differing on whether they arrive after today’s close or on Thursday.
Please wait processing your request...